Advpharma, Inc.

Harn-Jing Terng

Woan-Jen Lee

Pan-Chyr Yang

Jeremy J W Chen

Sung-Liang Yu

Hsuan-Yu Chen

Yi-Jen Lee

Chin-Yu Chen

Yeh-Tze Chou

Molecular markers for lung and colorectal carcinomas and methods of using them in blood sample assays are disclosed. The method comprises measuring the expression of the markers in a blood sample from a subject for detecting the presence and/or severity of lung and/or colorectal cancer, and for monitoring and/or assessing the prognosis of the subject's response to a cancer therapy. Also disclosed are kits for detecting, diagnosing, and/or monitoring lung or colorectal carcinomas.

Molecular markers for lung and colorectal carcinomas

Methods for determining a tumor in a human is disclosed. Also disclosed are methods for identifying adenocarcinoma, and methods for identifying squamous cell carcinoma in a human tumor sample. In addition, methods for predicting prognosis of metastasis and survival in a human having a tumor is disclosed.

Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients

The present invention discloses a method for treating cancer by using hCRMP1 and/or active fragments thereof, as well as the active fragments of hCRMP1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. A vector capable of expressing an hCRMP1, a variant of hCRMP1, a fragment of hCRMP1 or a variant of a fragment of hCRMP1 is also disclosed.

Compositions and methods of using CRMP-1 and its fragments for treating cancer

Growing community of inventors

Banciao, Taiwan

Harn-Jing Terng